Oncology provider strikes deal with DOJ in cartel probe

The Department of Justice has fined one of the country’s largest cancer treatment providers $100 million as part of a deferred prosecution agreement after the company admitted conspiring with a rival to eliminate competition.

Get unlimited access to all Global Competition Review content